Approval · Notice of Compliance 5615 · 1994
TIMODAL: Notice of Compliance 5615
Issued April 5, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5615
- Date
- April 5, 1994
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Elevated intraocular pressure therapy
Products in this notice
Medicinal ingredients
- TIMOLOL MALEATE 0.25 PER
- TIMOLOL MALEATE 0.5 PER